CO2-Patterns During Hyperoxia and Physical Exercise in COPD
CO2-Patterns During Hyperoxia and Physical Exercise in People With Severe COPD - a Randomized, Double-blind Cross Over Trial
연구 개요
상세 설명
Rationale:
Carbon dioxide partial pressure (PCO2) varies significantly in patients with advanced chronic obstructive pulmonary disease (COPD). Data from the Swedish LTOT Registry showed that PCO2 is an independent predictor for mortality and that there is a U-shaped relationship. Patients with advanced COPD who are still normocapnic at rest may still develop a clinically relevant, exercise-induced carbon dioxide (CO2) retention during exercise/ activity. It is also known that altered breathing patterns at night in COPD patients can lead to nocturnal hypercapnia, especially during REM sleep. The course of PCO2 cannot be reliably predicted by lung function parameters or resting blood gas analysis. Since exercise tests with blood gas control or nightly PCO2 monitoring are rarely performed in clinical routine, exercise induced CO2 retention often remains undetected. In the literature, there is little information on PCO2 behaviour under everyday conditions (with or without LTOT) such as rest, physical exertion and nightly sleep. Therefore, predictors that could describe the PCO2 patterns are missing. However, one former study by O'Donnel from 2002 showed that the change in CO2 under hyperoxia conditions could provide predictive information for the change in CO2 with exercise.
Objective:
Primary aim of this study is to investigate whether the change of PCO2 during a hyperoxia-test (10l/min O2 at rest) correlates with the change of PCO2 during walking exercise with either a: l/min O2 as prescribed; b: medical air; c: 10l/min O2.
Design:
This study is a randomized, controlled cross-over trial. Following an initial maximal incremental shuttle walk test (ISWT), the participant will perform 3 endurance shuttle walk tests (ESWT) at 85% of the maximum ISWT pace on three consecutive days (24h break between ESWTs). In a randomized order, participants will perform one ESWTs with O2-flow as prescribed (e.g. study day 1), one with medical air (same flow rate as prescribed oxygen) (e.g. study day 2) and one with 10l/min O2 (e.g. study day 3). An additional hyperoxia test (10l/min O2 for ten minutes; at resting condition) will be perfomed on each day prior to performing an ESWT.
연구 유형
등록 (예상)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Tessa Schneeberger
- 전화번호: +498652931540 +498652931540
- 이메일: TSchneeberger@Schoen-Klinik.de
연구 장소
-
-
-
Schönau am Königssee, 독일, 83471
- 모병
- Klinikum Berchtesgadener Land, Schön Kliniken
-
연락하다:
- Tessa Schneeberger, MSc
- 전화번호: 0049 - 8652 - 932730
- 이메일: tschneeberger@schoen-klinik.de
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 어린이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- COPD III/ IV
- 35mmHg < PCO2 <= 55mmHg (under resting conditions, breathing room air)
- Hypoxemia (PaO2<60mmHg) under room air conditions (rest or during exercise) or SpO2 <88% during exercise
- established oxygen therapy or given indication for oxygen therapy
- written informed consent
Exclusion Criteria:
- acute exacerbation of COPD
- exercise limiting cardiac or orthopedic comorbidites
- PaO2 <50mmHg at rest, breathing room air
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 크로스오버 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Randomised to begin with oxygen-supplementation at 10L/min during ESWT
Randomised order of tests starting with the 10L/min O2, during the ESWT followed by prescribed O2 flow rate or medical air in randomised order on seperate days
|
Supplemental O2 at rest of 10 l/min for ten minutes followed by supplemental O2 at the prescribed exercise O2-flow rate during ESWT.
Supplemental O2 at rest of 10 l/min for ten minutes followed by medical Air at prescribed O2 flow rate during ESWT.
Supplemental O2 at rest of 10 l/min for ten minutes followed by 10L/min O2 during ESWT.
|
|
실험적: Randomised to begin with medical air supplementation at prescibed O2 flow rate during ESWT
Randomised order of tests starting with the medical air during the ESWT followed by prescribed O2 flow rate or 10L/min O2 in randomised order on seperate days
|
Supplemental O2 at rest of 10 l/min for ten minutes followed by supplemental O2 at the prescribed exercise O2-flow rate during ESWT.
Supplemental O2 at rest of 10 l/min for ten minutes followed by medical Air at prescribed O2 flow rate during ESWT.
Supplemental O2 at rest of 10 l/min for ten minutes followed by 10L/min O2 during ESWT.
|
|
실험적: Randomised to begin with oxygen supplementation at prescibed O2 flow rate during ESWT
Randomised order of tests starting with the prescribed O2 flow rate, during the ESWT followed by 10L/min O2 or medical air in randomised order on seperate days
|
Supplemental O2 at rest of 10 l/min for ten minutes followed by supplemental O2 at the prescribed exercise O2-flow rate during ESWT.
Supplemental O2 at rest of 10 l/min for ten minutes followed by medical Air at prescribed O2 flow rate during ESWT.
Supplemental O2 at rest of 10 l/min for ten minutes followed by 10L/min O2 during ESWT.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in PCO2 during hyperoxia at rest
기간: Change from baseline to after 10 minutes breathing 10L/min oxygen
|
pCO2 measured by capillary blood gases taken before and after the hyperoxia test
|
Change from baseline to after 10 minutes breathing 10L/min oxygen
|
|
Change in PCO2 from rest to end exercise (endurance shuttle walk test)
기간: Change from baseline to the end of the ESWT, up to 20 minutes
|
pCO2 measured by capillary blood gases taken before and after the ESWT
|
Change from baseline to the end of the ESWT, up to 20 minutes
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Transcutaneous partial pressure of CO2 (TcPCO2) during hyperoxia test
기간: Continuously from baseline to 10 minutes breathing 10L/min oxygen
|
TcPCO2 measured by continuous transcutaneous recording via Sentec-Digital Monitor® (Sentec, Therwil, Switzerland)
|
Continuously from baseline to 10 minutes breathing 10L/min oxygen
|
|
Transcutaneous partial pressure of CO2 (TcPCO2) during endurance shuttle walk test
기간: Continuously during ESWT, up to 20 minutes
|
TcPCO2 measured by continuous transcutaneous recording via Sentec-Digital Monitor® (Sentec, Therwil, Switzerland)
|
Continuously during ESWT, up to 20 minutes
|
|
Breathing frequency during hyperoxia test
기간: Continuously from baseline to 10 minutes breathing 10L/min oxygen
|
Breathing frequency during the hyperoxia test measured by ApneaLink Air™ (ResMed)
|
Continuously from baseline to 10 minutes breathing 10L/min oxygen
|
|
Breathing frequency during endurance shuttle walk test
기간: Continuously during ESWT, up to 20 minutes
|
Breathing frequency during the ESWT measured by ApneaLink Air™ (ResMed)
|
Continuously during ESWT, up to 20 minutes
|
|
Heart rate during endurance shuttle walk test
기간: Continuously during ESWT, up to 20 minutes
|
Heart rate measured by continuous transcutaneous recordung via Sentec-Digital Monitor® (Sentec, Therwil, Switzerland)
|
Continuously during ESWT, up to 20 minutes
|
|
Heart rate during hyperoxia test
기간: Continuously from baseline to 10 minutes breathing 10L/min oxygen
|
Heart rate measured by continuous transcutaneous recordung via Sentec-Digital Monitor® (Sentec, Therwil, Switzerland)
|
Continuously from baseline to 10 minutes breathing 10L/min oxygen
|
|
Change of capillary partial pressure of O2 (pO2) during endurance shuttle walk test
기간: Change from baseline to the end of the ESWT, up to 20 minutes
|
pO2 measured by capillary blood gases taken before and after the ESWT
|
Change from baseline to the end of the ESWT, up to 20 minutes
|
|
Change of inspiratory capacity during endurance shuttle walk test
기간: Change from baseline to the end of the ESWT, up to 20 minutes
|
IC measured by SpiroSense (Pari) before and after the ESWT
|
Change from baseline to the end of the ESWT, up to 20 minutes
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 공유 지원 정보 유형
- 연구_프로토콜
- ICF
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .